LipidLaunch(TM) ALC-0315 LNP (GFP)

LipidLaunch(TM) ALC-0315 LNP (GFP) is a solution containing lipid nanoparticles (LNPs) composed of the ionizable cationic amino lipid ALC-0315 (Cay-34337), cholesterol (Cay-9003100, Cay-39088), the phospholipid 1,2-distearoyl-sn-glycero-3-PC (Cay-15100, Cay-39189), and the lipid excipient ALC-0159 (Cay-34336) at a molar ratio of 46.3:42.7:9.4:1.6 and encapsulating mRNA encoding the fluorescent protein GFP. It is intended for proof-of-concept experiments to determine whether ALC-0315-based LNPs can effectively lead to the expression of a protein of interest in a target cell type, either in vitro or in vivo. GFP has excitation/emission maxima of 488/507 nm, respectively. Suggested in vitro use: Thaw LNPs on ice with occasional gentle swirling (do not vortex). Using a gentle pipetting technique, dilute 1:100-1:500 in complete cell culture media (with serum) and add to subconfluent adherent cells in a fluorescence imaging-compatible tissue culture plate. Expression of GFP may be detectable as early as six hours after treatment. Optimal conditions are highly dependent on cell type.Emission: 507 nm. Excitation: 488 nm. Formulation: (Request formulation change), TBS, with 10% sucrose.